• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

人脑脊液中β/A4淀粉样蛋白前体的可溶性衍生物同时进行了N-糖基化和O-糖基化。

Soluble derivatives of beta/A4 amyloid protein precursor in human cerebrospinal fluid are both N- and O-glycosylated.

作者信息

Saito F, Yanagisawa K, Miyatake T

机构信息

Department of Neurology, School of Medicine, Tokyo Medical and Dental University, Japan.

出版信息

Brain Res Mol Brain Res. 1993 Jul;19(1-2):171-4. doi: 10.1016/0169-328x(93)90164-k.

DOI:10.1016/0169-328x(93)90164-k
PMID:8361341
Abstract

The linkage of the glycan chain to the beta/A4 amyloid protein precursor (APP) in cerebrospinal fluid (CSF) was studied by Western blot analysis. The apparent molecular weight of APP in CSF was reduced from 103 to 100 kDa by N-glycanase, and to 96 kDa by O-glycanase treatment, respectively. These data indicate that APP is both N- and O-glycosylated in one molecule. The extent of glycosylation of APP was not altered in the CSF from patients with Alzheimer's disease.

摘要

通过蛋白质免疫印迹分析研究了脑脊液(CSF)中聚糖链与β/A4淀粉样蛋白前体(APP)的连接。用N-糖苷酶处理后,脑脊液中APP的表观分子量从103 kDa降至100 kDa,用O-糖苷酶处理后降至96 kDa。这些数据表明APP在一个分子中同时进行了N-糖基化和O-糖基化。阿尔茨海默病患者脑脊液中APP的糖基化程度没有改变。

相似文献

1
Soluble derivatives of beta/A4 amyloid protein precursor in human cerebrospinal fluid are both N- and O-glycosylated.人脑脊液中β/A4淀粉样蛋白前体的可溶性衍生物同时进行了N-糖基化和O-糖基化。
Brain Res Mol Brain Res. 1993 Jul;19(1-2):171-4. doi: 10.1016/0169-328x(93)90164-k.
2
Developmental changes of sialylation of soluble beta/A4 amyloid protein precursor derivatives in human cerebrospinal fluid.人脑脊液中可溶性β/A4淀粉样蛋白前体衍生物唾液酸化的发育变化
Brain Res Mol Brain Res. 1994 Dec;27(2):320-2. doi: 10.1016/0169-328x(94)90016-7.
3
Identification of novel N-terminal fragments of amyloid precursor protein in cerebrospinal fluid.鉴定脑脊液中淀粉样前体蛋白的新型 N 端片段。
Exp Neurol. 2010 Jun;223(2):351-8. doi: 10.1016/j.expneurol.2009.06.011. Epub 2009 Jun 25.
4
Quantitative changes in the amyloid beta A4 precursor protein in Alzheimer cerebrospinal fluid.阿尔茨海默病脑脊液中β淀粉样蛋白A4前体蛋白的定量变化。
Neurosci Lett. 1991 Mar 11;124(1):69-73. doi: 10.1016/0304-3940(91)90824-d.
5
Levels of alpha- and beta-secretase cleaved amyloid precursor protein in the cerebrospinal fluid of Alzheimer's disease patients.阿尔茨海默病患者脑脊液中α-和β-分泌酶切割的淀粉样前体蛋白水平。
Neurosci Lett. 2000 Jan 14;278(3):169-72. doi: 10.1016/s0304-3940(99)00929-5.
6
Detection of amyloid beta protein precursor immunoreactivity in normal and Alzheimer's disease cerebrospinal fluid.
Life Sci. 1990;47(13):1163-71. doi: 10.1016/0024-3205(90)90177-s.
7
Decreased levels of soluble amyloid beta-protein precursor in cerebrospinal fluid of live Alzheimer disease patients.老年痴呆症患者脑脊液中可溶性淀粉样β蛋白前体水平降低。
Proc Natl Acad Sci U S A. 1992 Apr 1;89(7):2551-5. doi: 10.1073/pnas.89.7.2551.
8
The beta-amyloid protein precursor of Alzheimer disease has soluble derivatives found in human brain and cerebrospinal fluid.阿尔茨海默病的β-淀粉样蛋白前体在人脑和脑脊液中发现有可溶性衍生物。
Proc Natl Acad Sci U S A. 1989 Aug;86(16):6338-42. doi: 10.1073/pnas.86.16.6338.
9
Secretory pathway of beta/A4 amyloid protein precursor in familial Alzheimer's disease with Val717 to Ile mutation.伴有717位缬氨酸突变为异亮氨酸的家族性阿尔茨海默病中β/A4淀粉样蛋白前体的分泌途径
Neurosci Lett. 1992 Sep 14;144(1-2):43-5. doi: 10.1016/0304-3940(92)90711-f.
10
C-terminal fragments of the amyloid precursor protein in cerebrospinal fluid as potential biomarkers for Alzheimer disease.脑脊液中淀粉样前体蛋白的 C 端片段作为阿尔茨海默病的潜在生物标志物。
Sci Rep. 2017 May 30;7(1):2477. doi: 10.1038/s41598-017-02841-7.

引用本文的文献

1
Glycosylation in neuroinflammation: mechanisms, implications, and therapeutic strategies for neurodegenerative diseases.神经炎症中的糖基化:神经退行性疾病的机制、影响及治疗策略
Transl Neurodegener. 2025 Sep 22;14(1):47. doi: 10.1186/s40035-025-00506-4.
2
Recent Advances in Mass Spectrometry-Based Studies of Post-Translational Modifications in Alzheimer's Disease.基于质谱的阿尔茨海默病翻译后修饰研究的最新进展
Mol Cell Proteomics. 2025 May 29;24(7):101003. doi: 10.1016/j.mcpro.2025.101003.
3
Protein posttranslational modifications in health and diseases: Functions, regulatory mechanisms, and therapeutic implications.
健康与疾病中的蛋白质翻译后修饰:功能、调控机制及治疗意义
MedComm (2020). 2023 May 2;4(3):e261. doi: 10.1002/mco2.261. eCollection 2023 Jun.
4
The Glycobiology of Pulmonary Arterial Hypertension.肺动脉高压的糖生物学
Metabolites. 2022 Apr 1;12(4):316. doi: 10.3390/metabo12040316.
5
Implications of Glycosylation in Alzheimer's Disease.糖基化在阿尔茨海默病中的意义。
Front Neurosci. 2021 Jan 13;14:625348. doi: 10.3389/fnins.2020.625348. eCollection 2020.
6
The non-peptidic δ-opioid receptor agonist Tan-67 mediates neuroprotection post-ischemically and is associated with altered amyloid precursor protein expression, maturation and processing in mice.非肽类 δ 阿片受体激动剂 Tan-67 介导缺血后神经保护作用,并与小鼠淀粉样前体蛋白表达、成熟和加工改变相关。
J Neurochem. 2018 Feb;144(3):336-347. doi: 10.1111/jnc.14265. Epub 2017 Dec 19.
7
LW-AFC Effects on -glycan Profile in Senescence-Accelerated Mouse Prone 8 Strain, a Mouse Model of Alzheimer's Disease.LW-AFC对衰老加速易患8型小鼠(一种阿尔茨海默病小鼠模型)聚糖谱的影响。
Aging Dis. 2017 Feb 1;8(1):101-114. doi: 10.14336/AD.2016.0522. eCollection 2017 Feb.
8
Multifunctional roles of enolase in Alzheimer's disease brain: beyond altered glucose metabolism.烯醇化酶在阿尔茨海默病大脑中的多功能作用:超越葡萄糖代谢改变
J Neurochem. 2009 Nov;111(4):915-33. doi: 10.1111/j.1471-4159.2009.06397.x. Epub 2009 Sep 23.